MCID: SPL012
MIFTS: 46

Splenic Disease

Categories: Immune diseases, Blood diseases

Aliases & Classifications for Splenic Disease

MalaCards integrated aliases for Splenic Disease:

Name: Splenic Disease 12 14
Splenic Diseases 42 69
Abnormality of the Spleen 29
Spleen Diseases 41
Spleen Disease 12
Dyssplenism 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2529
ICD10 33 D73 D73.9
ICD9CM 35 289.50
MeSH 42 D013158
NCIt 47 C35823
UMLS 69 C0037997

Summaries for Splenic Disease

MedlinePlus : 41 your spleen is an organ above your stomach and under your ribs on your left side. it is about as big as your fist. the spleen is part of your lymphatic system, which fights infection and keeps your body fluids in balance. it contains white blood cells that fight germs. your spleen also helps control the amount of blood in your body, and destroys old and damaged cells. certain diseases might cause your spleen to swell. you can also damage or rupture your spleen in an injury, especially if it is already swollen. if your spleen is too damaged, you might need surgery to remove it. you can live without a spleen. other organs, such as your liver, will take over some of the spleen's work. without a spleen, however, your body will lose some of its ability to fight infections.

MalaCards based summary : Splenic Disease, also known as splenic diseases, is related to chronic laryngitis and landau-kleffner syndrome, and has symptoms including hepatosplenomegaly An important gene associated with Splenic Disease is THPO (Thrombopoietin), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Primary immunodeficiency. The drugs Cyclophosphamide and Lenograstim have been mentioned in the context of this disorder. Affiliated tissues include spleen, bone and bone marrow.

Wikipedia : 72 Splenic diseases include splenomegaly, where the spleen is enlarged for various reasons. On the other... more...

Related Diseases for Splenic Disease

Diseases related to Splenic Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 128)
id Related Disease Score Top Affiliating Genes
1 chronic laryngitis 10.8 HBB THPO
2 landau-kleffner syndrome 10.7 F2 HBB
3 bile duct cystadenoma 10.7 F2 HBB
4 mental depression 10.7 CD40LG THPO
5 lockwood feingold syndrome 10.7 CD40LG F2
6 non-hodgkin lymphoma, during pregnancy 10.7 ALB F2
7 middle ear carcinoma 10.7 ALB CD40LG
8 centronuclear myopathy 5 10.7 CD40LG HBB
9 microinvasive cervical squamous cell carcinoma 10.7 ALB CD40LG
10 oral cavity carcinoma in situ 10.7 ALB F2
11 female infertility of uterine origin 10.6 ALB F2
12 retromolar area cancer 10.6 CD40LG THPO
13 estrogen excess 10.6 ALB CD40LG
14 pancreatic cystadenocarcinoma 10.6 ALB F2
15 duane retraction syndrome 10.6 ALB F2
16 maxillary sinusitis 10.6 CD40LG F2
17 adie pupil 10.6 ALB CD40LG
18 angelucci's syndrome 10.6 ALB F2
19 autonomic peripheral neuropathy 10.6 CD40LG THPO
20 dyskeratosis congenita 10.6 ALB CD40LG
21 immune-complex glomerulonephritis 10.6 ALB CD40LG
22 atrophic vulva 10.6 ALB F2
23 motion sickness 10.6 ALB CD40LG
24 hyperthyroidism 10.6 F2 F3
25 pyridoxine deficiency anemia 10.6 F2 F3
26 adrenal gland disease 10.6 ALB CD40LG
27 46,xy ovotesticular disorder of sex development 10.6 F2 F3
28 von willibrand disease, type 3 10.6 F2 F3
29 myiasis 10.6 F2 F3
30 testicular gonadoblastoma 10.6 F2 F3
31 rectum neuroendocrine neoplasm 10.6 F2 F3
32 vulvar sarcoma 10.6 ALB CD40LG
33 midline cystocele 10.6 F2 F3
34 hereditary amyloidosis 10.6 CD40LG F3
35 female breast cancer 10.6 F2 F3
36 brain stem glioma 10.6 F2 F3
37 dermatomycosis 10.5 ALB CD40LG
38 sporotrichosis 10.5 F2 F3
39 central nervous system germ cell tumor 10.5 F2 F3
40 pyrimidine metabolic disorder 10.5 ALB CD40LG
41 poems syndrome 10.5 EPO THPO
42 kohler's disease 10.5 ALB F2
43 spinal polio 10.5 CD40LG THPO
44 lymphatic system cancer 10.5 F2 F3
45 common cold 10.5 ALB CD40LG
46 rete ovarii adenoma 10.5 ALB F2
47 facioscapulohumeral muscular dystrophy 1 10.5 F2 F3
48 lethal congenital contracture syndrome 10.5 F2 F3
49 cavernous lymphangioma 10.5 CD40LG F3
50 timothy syndrome type 2 10.5 EPO HBB

Graphical network of the top 20 diseases related to Splenic Disease:



Diseases related to Splenic Disease

Symptoms & Phenotypes for Splenic Disease

UMLS symptoms related to Splenic Disease:


hepatosplenomegaly

Drugs & Therapeutics for Splenic Disease

Drugs for Splenic Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 520)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
2
Lenograstim Approved Phase 4,Phase 3,Phase 2,Phase 1 135968-09-1
3
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
4
Nitroglycerin Approved, Investigational Phase 4 55-63-0 4510
5
Pravastatin Approved Phase 4 81093-37-0 54687
6
Rifaximin Approved, Investigational Phase 4 80621-81-4 6436173
7
Benzocaine Approved Phase 4,Phase 3,Phase 2 1994-09-7, 94-09-7 2337
8
Dalteparin Approved Phase 4,Phase 3,Phase 2 9005-49-6
9
Dipyridamole Approved Phase 4 58-32-2 3108
10
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2 9005-49-6 772 46507594
11 Nadroparin Approved Phase 4 9041-08-1
12
Warfarin Approved Phase 4 81-81-2 6691 54678486
13 Thiotepa Approved Phase 4,Phase 2,Phase 3 52-24-4 5453
14
Levoleucovorin Approved Phase 4,Phase 2,Phase 1 68538-85-2
15
Pyrimethamine Approved, Vet_approved Phase 4,Phase 1 58-14-0 4993
16
Spiramycin Approved Phase 4 24916-50-5
17
Sulfadiazine Approved, Vet_approved Phase 4 68-35-9 5215
18
Clonazepam Approved, Illicit Phase 4 1622-61-3 2802
19
Norepinephrine Approved Phase 4 51-41-2 439260
20
Desogestrel Approved Phase 4 54024-22-5 40973
21
Etonogestrel Approved, Investigational Phase 4 54048-10-1 40976 6917715
22
Clopidogrel Approved, Nutraceutical Phase 4 120202-66-6, 113665-84-2 60606
23 tannic acid Approved, Nutraceutical Phase 4,Phase 3,Phase 2
24
Glucosamine Approved, Nutraceutical Phase 4 3416-24-8 439213
25
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 59-30-3 6037
26
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 58-05-9 143 6006
27
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4,Phase 2 1406-16-2
28 Analgesics Phase 4,Phase 3,Phase 2,Phase 1
29 Analgesics, Non-Narcotic Phase 4,Phase 2,Phase 1
30 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1
31 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 2
32 Antimetabolites Phase 4,Phase 3,Phase 2,Phase 1
33 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1
34 Cyclooxygenase Inhibitors Phase 4,Phase 2
35 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1
36 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1
37 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
38 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Phase 1
39 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
40 Liver Extracts Phase 4,Phase 3,Phase 2,Phase 1
41 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1
42 Antilymphocyte Serum Phase 4,Phase 2,Phase 3,Phase 1
43 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1
44 Protective Agents Phase 4,Phase 2,Phase 1
45 Neurotransmitter Agents Phase 4,Phase 3,Phase 1,Phase 2
46 Psychotropic Drugs Phase 4,Phase 3,Phase 1,Phase 2
47
Serotonin Phase 4,Phase 3 50-67-9 5202
48 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
49 Hormones Phase 4,Phase 3,Phase 2,Phase 1
50 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 597)

id Name Status NCT ID Phase Drugs
1 Studies of Traditional Chinese Medicine Clinical Efficacy Evaluation Index Completed NCT01502943 Phase 4 Louxiangdan Tongxin granules;TCM granules placebo;Chixiangshen Tongxin granules;TCM granule placebo plus western basis treatment;Western basis treatment
2 A Safety and Efficacy Study of Two Dose Levels of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease Completed NCT01132690 Phase 4 Taliglucerase alfa
3 Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy Completed NCT02019784 Phase 4 Rifaximin-α;Placebo Oral Tablet
4 Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection Completed NCT02247414 Phase 4 Warfarin;Dipyridamole;Aspirin;Low Molecular Weight Heparin
5 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00003398 Phase 4 cyclophosphamide;thiotepa
6 A Clinical Trial of the Vessel Sealing System (LigaSure) in Azygoportal Disconnection and Splenectomy in Patients With Portal Hypertension Completed NCT00965744 Phase 4
7 A Comparison of Two Colonoscopic Withdrawal Techniques Completed NCT01554098 Phase 4
8 Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy Recruiting NCT02238444 Phase 4 Warfarin;Dipyridamole;Aspirin;Low Molecular Weight Heparin
9 Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis Recruiting NCT00004317 Phase 4 Leucovorin calcium;Pyrimethamine;Spiramycin;Sulfadiazine
10 Neurochemical, Metabonomics and Neuroimaging Characterization of TCM Diagnostic Subtypes of Major Depression Disorder Recruiting NCT02346682 Phase 4 venlafaxine
11 Phase 4 Study to Evaluate the Effect of Velaglucerase Alfa (VPRIV®) on Patients With Type 1 Gaucher Disease Through the IV Administration of VPRIV® Over 2 Years Recruiting NCT02574286 Phase 4 Velaglucerase alfa
12 Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative Patients Recruiting NCT02499185 Phase 4
13 Contraception in Women With Sickle Cell Disease Active, not recruiting NCT02594462 Phase 4 etonogestrel-releasing implant contraceptive
14 Pharmacokinetics, Pharmacodynamics And Safety Study Of Elelyso(tm) In Pediatric Subjects With Type 1 Gaucher Disease Not yet recruiting NCT03021941 Phase 4 Elelyso 60 units/kg
15 Efficacy and Safety of 1612 Capsules in aMnestic Mild Cognitive Impairment Not yet recruiting NCT02982642 Phase 4 1612 capsule;Placebos
16 Contrast-Enhanced US of Spleen, Liver and Kidney Unknown status NCT00190281 Phase 3
17 Effect of Traditional Chinese Medicine on Outcomes in Patients With Severe / Very Severe COPD Unknown status NCT02270424 Phase 3 Salmeterol / fluticasone (Seretide®);Bufeijianpi granule;Bufeiyishen granule;Yiqizishen granule;Placebo Bufeijianpi granule;Placebo Bufeiyishen granule;Placebo Yiqizishen granule
18 Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma Unknown status NCT00003924 Phase 3
19 A Randomized Comparative Effectiveness Research Trial of Three Treatments for COPD Patients Unknown status NCT01836016 Phase 3 Salbutamol (Ventolin®);Formoterol (Oxis Turbuhaler®);Salmeterol / fluticasone (Seretide®);Bufei granule;Bufeijianpi granule;Bufeiyishen granule;Yiqizishen granule;conventional medicine + TCM
20 Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma Unknown status NCT00003338 Phase 2, Phase 3
21 Long-Term Effects of Hydroxyurea in Children With Sickle Cell Anemia (The BABY HUG Follow-up Study) Unknown status NCT00890396 Phase 3
22 Tissue Distribution of F18-FDG Labelled Autologous Bone Marrow Derived Stem Cells in Patients With Type 2 DM Unknown status NCT01694173 Phase 2, Phase 3
23 Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma Unknown status NCT00052936 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
24 Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects. Completed NCT02141516 Phase 3
25 A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease Completed NCT01422187 Phase 3 Taliglucerase alfa
26 Plant Cell Expressed Recombinant Human Glucocerebrosidase Extension Trial Completed NCT00705939 Phase 3 Taliglucerase alfa
27 Oral Miglustat in Adult Patients With Stable Type 1 Gaucher Disease Completed NCT00319046 Phase 3 miglustat
28 A Phase III Trial to Assess the Safety and Efficacy of Plant Cell Expressed GCD in Patients With Gaucher Disease Completed NCT00376168 Phase 3 Plant cell expressed recombinant glucocerebrosidase (prGCD);Plant cell expressed recombinant glucocerebrosidase (prGCD)
29 A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE) Completed NCT00891202 Phase 3 Eliglustat tartrate;Placebo
30 Study of Velaglucerase Alfa Enzyme Replacement Therapy in Japanese Patients With Gaucher Disease Completed NCT01614574 Phase 3
31 Multicenter Extension Study of Velaglucerase Alfa in Japanese Patients With Gaucher Disease Completed NCT01842841 Phase 3 velaglucerase alfa
32 G-CSF and Erythropoetin in Survival of Patients With Decompensated Liver Disease Completed NCT01384565 Phase 3 G-CSF+EPO;Placebo
33 Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients Completed NCT02523638 Phase 3 Pegylated-Proline-Interferon alpha-2b in a Pre-filled Pen
34 Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis Completed NCT00255567 Phase 3 Sodium Stibogluconate;Paromomycin sulphate;SSG and Paromomycin sulphate
35 Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera Completed NCT01949805 Phase 3 Peg-P-IFN-alpha-2b (AOP2014);Hydroxyurea
36 A Multicenter Extension Study of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease Completed NCT01411228 Phase 3 Taliglucerase alfa
37 Trial Comparing Chlorambucil to Fludarabine in Patients With Advanced Waldenström Macroglobulinemia Completed NCT00566332 Phase 3 Chlorambucil;Fludarabine
38 SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease Completed NCT00002495 Phase 3 doxorubicin hydrochloride;vinblastine
39 Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase Completed NCT00478647 Phase 2, Phase 3
40 An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher Disease Completed NCT00635427 Phase 3
41 A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE) Completed NCT01074944 Phase 3 Eliglustat tartrate
42 A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE) Completed NCT00943111 Phase 3 Eliglustat tartrate;Imiglucerase
43 Phase III Study of ISU302 in Patients With Type 1 Gaucher Disease Completed NCT02770625 Phase 3 ISU302
44 Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases Completed NCT00438958 Phase 3
45 A Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Gaucher Disease Completed NCT00430625 Phase 3
46 Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder Completed NCT00755040 Phase 3 cyclosporine ophthalmic emulsion
47 Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease Completed NCT00003414 Phase 3 busulfan;cyclophosphamide;cyclosporine
48 Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer Completed NCT00265837 Phase 3
49 Comparison Between Open and Laparoscopic Splenic Aneurysms Repair Completed NCT01387828 Phase 3
50 Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) ERT Compared With Imiglucerase in Type I Gaucher Disease Completed NCT00553631 Phase 3

Search NIH Clinical Center for Splenic Disease

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: splenic diseases

Genetic Tests for Splenic Disease

Genetic tests related to Splenic Disease:

id Genetic test Affiliating Genes
1 Abnormality of the Spleen 29

Anatomical Context for Splenic Disease

MalaCards organs/tissues related to Splenic Disease:

39
Spleen, Bone, Bone Marrow, Liver, B Cells, T Cells, Kidney

Publications for Splenic Disease

Articles related to Splenic Disease:

(show all 22)
id Title Authors Year
1
Molecular detection of vector-borne pathogens in blood and splenic samples from dogs with splenic disease. ( 28285583 )
2017
2
No evidence of splenic disease in patients with splenic marginal zone lymphoma undergoing splenectomy for autoimmune hemolytic anemia after monotherapy with rituximab. ( 27082039 )
2016
3
Correction: In Vivo MRI Assessment of Hepatic and Splenic Disease in a Murine Model of Schistosmiasis. ( 26474175 )
2015
4
In Vivo MRI Assessment of Hepatic and Splenic Disease in a Murine Model of Schistosmiasis. ( 26394390 )
2015
5
Molecular prevalence of Bartonella, Babesia, and hemotropic Mycoplasma sp. in dogs with splenic disease. ( 22092618 )
2011
6
Use of an ultrasonically activated scalpel for splenectomy in 10 dogs with naturally occurring splenic disease. ( 15860110 )
2005
7
Experience with benign splenic disease. ( 15571023 )
2004
8
Surgical management of splenic disease. ( 11226539 )
2001
9
Ultrasonographic appearance of splenic disease in 101 cats. ( 11678567 )
2001
10
Community-acquired Staphylococcus epidermidis endocarditis complicated by splenic disease 9 years after aortic valve replacement. ( 10680992 )
1999
11
Surgical aspects of splenic disease and lymphoma. ( 9663186 )
1998
12
Contrast-enhanced MR imaging of diffuse and focal splenic disease with use of magnetic starch microspheres. ( 8061436 )
1994
13
Focal splenic disease demonstrated by ultrasound and computed tomography. ( 3884617 )
1985
14
Rectus sheath hematoma mimicking acute splenic disease. ( 6225332 )
1983
15
Splenic disease. ( 625270 )
1978
16
Hepato splenic disease caused by Bilharzia haematobium in Upper Egypt. ( 4817356 )
1974
17
Elective splenectomy for primary hematologic and splenic disease. ( 5270604 )
1970
18
Splenic disease diagnosis by radioisotope scanning. ( 14004363 )
1962
19
Surgical aspects of splenic disease. ( 14387371 )
1955
20
Surgical aspects of splenic disease. ( 14387366 )
1955
21
Effect of splenic function and splenic disease on female physiology, with a brief analysis of 182 gestations after splenectomy. ( 15436199 )
1950
22
Surgical aspects of splenic disease. ( 18141301 )
1949

Variations for Splenic Disease

Expression for Splenic Disease

Search GEO for disease gene expression data for Splenic Disease.

Pathways for Splenic Disease

Pathways related to Splenic Disease according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1
Show member pathways
12.1 ALB F2 F3 HBB THPO
2 10.52 CD40LG RFXANK

GO Terms for Splenic Disease

Cellular components related to Splenic Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cell surface GO:0009986 9.56 ADAM17 CD40LG EPO F3
2 extracellular region GO:0005576 9.5 ALB CD40LG EPO F2 F3 HBB
3 blood microparticle GO:0072562 9.33 ALB F2 HBB
4 extracellular space GO:0005615 9.17 ALB CD40LG EPO F2 F3 HBB

Biological processes related to Splenic Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 acute-phase response GO:0006953 9.16 EPO F2
2 blood coagulation GO:0007596 9.13 F2 F3 HBB
3 positive regulation of protein phosphorylation GO:0001934 8.8 ADAM17 F2 THPO

Sources for Splenic Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....